Bal Pharma Ltd (BALP)

Currency in INR
86.69
-0.39(-0.45%)
Closed·
BALP Scorecard
Full Analysis
Trading at a low earnings multiple
BALP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
86.0188.29
52 wk Range
78.06157.98
Key Statistics
Bid/Ask
86.69 / 87.48
Prev. Close
87.08
Open
87.11
Day's Range
86.01-88.29
52 wk Range
78.06-157.98
Volume
10.12K
Average Volume (3m)
21.23K
1-Year Change
-41.1%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BALP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Bal Pharma Ltd Company Profile

Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs. It also provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostate enlargement, renal calculi, male infertility, and women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; and cardiac care products under the Secremet and Servace brands. In addition, the company offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment, etc.; and various formulations, including tablets, capsules, syrups, suspensions, ophthalmic, creams, and ointments. Further, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. The company exports its products to approximately 30 countries. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.

Employees
868
Market
India

Compare BALP to Peers and Sector

Metrics to compare
BALP
Peers
Sector
Relationship
P/E Ratio
19.0x26.0x−0.5x
PEG Ratio
−3.050.150.00
Price/Book
1.8x3.1x2.6x
Price / LTM Sales
0.5x2.3x3.3x
Upside (Analyst Target)
-13.7%38.7%
Fair Value Upside
Unlock3.3%5.0%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.58%
Dividend Yield
1.38%
Industry Median 0.74%
Annualised payout
1.20
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 29, 2025
EPS / Forecast
3.40 / --
Revenue / Forecast
829.59M / --
EPS Revisions
Last 90 days

BALP Income Statement

People Also Watch

235.14
BOB
-2.46%
281.00
ADTB
-1.47%
50.82
OLAE
+4.63%
123.95
MRPL
+0.37%

FAQ

What Stock Exchange Does Bal Pharma Ltd Trade On?

Bal Pharma Ltd is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Bal Pharma Ltd?

The stock symbol for Bal Pharma Ltd is "BALP."

What Is the Bal Pharma Ltd Market Cap?

As of today, Bal Pharma Ltd market cap is 1.38B.

What Is Bal Pharma Ltd's Earnings Per Share (TTM)?

The Bal Pharma Ltd EPS (TTM) is 4.58.

From a Technical Analysis Perspective, Is BALP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bal Pharma Ltd Stock Split?

Bal Pharma Ltd has split 0 times.

How Many Employees Does Bal Pharma Ltd Have?

Bal Pharma Ltd has 868 employees.

What is the current trading status of Bal Pharma Ltd (BALP)?

As of 27 Aug 2025, Bal Pharma Ltd (BALP) is trading at a price of 86.69, with a previous close of 87.08. The stock has fluctuated within a day range of 86.01 to 88.29, while its 52-week range spans from 78.06 to 157.98.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.